Metabolomic Profiling of Red Blood Cells to Identify Molecular Markers of Methotrexate Response in the Collagen Induced Arthritis Mouse Model
Although methotrexate (MTX) is the first line disease-modifying therapy used in the treatment of autoimmune arthritis, it is limited by its unpredictable and variable response profile and lack of therapeutic biomarkers to predict or monitor therapeutic response. The purpose of this work is to evalua...
Main Authors: | Yezan M. Salamoun, Kishore Polireddy, Yu Kyoung Cho, Ryan Sol Funk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Future Pharmacology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9879/2/4/38 |
Similar Items
-
Methotrexate Disposition, Anti-Folate Activity, and Metabolomic Profiling to Identify Molecular Markers of Disease Activity and Drug Response in the Collagen-Induced Arthritis Mouse Model
by: Yezan M. Salamoun, et al.
Published: (2021-12-01) -
Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy
by: Matthew R. Medcalf, et al.
Published: (2021-11-01) -
LC-MS-based rheumatoid arthritis serum metabolomics reveals the role of deoxyinosine in attenuating collagen-induced arthritis in mice
by: Delai Xu, et al.
Published: (2024-05-01) -
Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis
by: Ryan Sol Funk, et al.
Published: (2021-12-01) -
Folate-Targeted Liposomal Formulations Improve Effects of Methotrexate in Murine Collagen-Induced Arthritis
by: Diana Guimarães, et al.
Published: (2022-01-01)